Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asuransi Bintang Tbk (ASBI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Asuransi Bintang Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Asuransi Bintang Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asuransi Bintang Tbk trades at Rp416 (market cap 142.84B, 1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Asuransi Bintang Tbk and Brigit Biofarmaka Teknologi Tbk. are close in size by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 1K). Which is the better fit depends on your goals.

ASBIOBAT
Market Cap
142.84B160.57B
Volume
1K2.51M
Lot
1025.09K
Turnover
412.6K636.74M
Average Price
412.6253.78
Value
412.6K636.74M
Indicative Equilibrium Price
242
Indicative Equilibrium Volume
146

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASBI
View details
OBAT
View details

About Asuransi Bintang Tbk

PT Asuransi Bintang Tbk (the Company) was established on March 17, 1955 based on Notarial Deed No. 63 of Raden Meester Soewandi, a public notary in Jakarta. The just passing 1999 marked the Bintang's complete 44 service in Indonesia. Along this period, the Company established on March 17th, 1955 has been proving itself as in insurance company persistently holding its commitment. In 1989, Bintang took important step by entering the stock exchange and registered itself at Jakarta and Surabaya Stock Exchange.

Read more on ASBI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT